Verneuil sur Seine, France

Michael Burnbridge


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Burnbridge: Innovator in Pharmaceutical Compounds

Introduction

Michael Burnbridge is a notable inventor based in Verneuil sur Seine, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have potential applications in cancer treatment. His work exemplifies the intersection of innovation and healthcare.

Latest Patents

Michael Burnbridge holds a patent for dihydroindolone compounds, which includes a process for their preparation and pharmaceutical compositions containing them. The compounds are defined by a specific formula and are designed to be used in medicinal products that are effective in treating cancer. This patent highlights his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Throughout his career, Michael has been associated with Les Laboratoires Servier, a prominent pharmaceutical company. His role at the company has allowed him to focus on research and development, contributing to the creation of innovative therapeutic solutions. His expertise in medicinal chemistry has been instrumental in the progress of various pharmaceutical projects.

Collaborations

Michael has collaborated with several talented individuals in his field, including Jean-Claude Ortuno and Alexis Cordi. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the overall quality of their research.

Conclusion

In summary, Michael Burnbridge is a dedicated inventor whose work in pharmaceutical compounds has the potential to make a significant impact on cancer treatment. His innovative spirit and collaborative efforts continue to drive advancements in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…